Editas treats first patient in sickle cell trial as FDA lifts partial hold

Submitted by admin on July 29, 2022 - 10:03am

Source:

BioPharma Dive

News Tags:

Editas Medicine

clinical trials

CRISPR

gene editing

sickle cell disease

Headline:

Editas treats first patient in sickle cell trial as FDA lifts partial hold

snippet:

Editas Medicine has treated the first patient in a trial of its experimental gene editing treatment for sickle cell disease, a step forward in the company’s development of CRISPR-based medicines.

Search form

You are here

Editas treats first patient in sickle cell trial as FDA lifts partial hold

Editas treats first patient in sickle cell trial as FDA lifts partial hold